EP3554648B1 - Masque avec apport d'air primaire et secondaire - Google Patents

Masque avec apport d'air primaire et secondaire Download PDF

Info

Publication number
EP3554648B1
EP3554648B1 EP17822191.7A EP17822191A EP3554648B1 EP 3554648 B1 EP3554648 B1 EP 3554648B1 EP 17822191 A EP17822191 A EP 17822191A EP 3554648 B1 EP3554648 B1 EP 3554648B1
Authority
EP
European Patent Office
Prior art keywords
pressure generating
interface device
conduit
generating device
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP17822191.7A
Other languages
German (de)
English (en)
Other versions
EP3554648A1 (fr
Inventor
Richard Thomas Haibach
Jonathan Sayer GRASHOW
Lauren Patricia CHODKOWSKI
Robert William BAIKO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips NV filed Critical Koninklijke Philips NV
Publication of EP3554648A1 publication Critical patent/EP3554648A1/fr
Application granted granted Critical
Publication of EP3554648B1 publication Critical patent/EP3554648B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B19/00—Machines or pumps having pertinent characteristics not provided for in, or of interest apart from, groups F04B1/00 - F04B17/00
    • F04B19/006—Micropumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A61M16/0066—Blowers or centrifugal pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A—HUMAN NECESSITIES
    • A62—LIFE-SAVING; FIRE-FIGHTING
    • A62B—DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
    • A62B18/00—Breathing masks or helmets, e.g. affording protection against chemical agents or for use at high altitudes or incorporating a pump or compressor for reducing the inhalation effort
    • A62B18/006—Breathing masks or helmets, e.g. affording protection against chemical agents or for use at high altitudes or incorporating a pump or compressor for reducing the inhalation effort with pumps for forced ventilation
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B43/00—Machines, pumps, or pumping installations having flexible working members
    • F04B43/02—Machines, pumps, or pumping installations having flexible working members having plate-like flexible members, e.g. diaphragms
    • F04B43/04—Pumps having electric drive
    • F04B43/043—Micropumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022—Control means therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0683—Holding devices therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/08—Supports for equipment
    • A61M2209/088—Supports for equipment on the body

Definitions

  • the present invention relates to respiratory interface devices for transporting a gas to and/or from an airway of a user and, in particular, to a respiratory interface device that includes both primary and secondary air delivery.
  • Non-invasive ventilation and pressure support therapies involve the placement of a patient interface device including a mask component on the face of a patient.
  • the mask component may be, without limitation, a nasal mask that covers the patient's nose, a nasal cushion having nasal prongs that are received within the patient's nares, a nasal/oral mask that covers the nose and mouth, or a full face mask that covers the patient's face.
  • the patient interface device interfaces the ventilator or pressure support device with the airway of the patient so that a flow of breathing gas can be delivered from a pressure/flow generating device to the airway of the patient. That is, the patient interface device is a part of a respiratory interface device that further includes a patient circuit and a pressure generating device.
  • the pressure generating device is structured to generate a pressure in a fluid, i.e., in normal operation in the atmosphere the pressure generating device generates a flow of air.
  • the patient circuit is structured to couple the pressure generating device to the patient interface device by elements such as, but not limited to, hoses or other conduits.
  • the pressure generating device is coupled to, and in fluid communication with, the patient interface device via the patient circuit.
  • the hose or conduit conventionally has a diameter of between 15 mm to 22 mm.
  • a hose or conduit of this size may make the user aware of the hose during use. That is, the hose has a sufficient mass and bulk so that the user may feel the hose during use. Further, use of a smaller diameter hose is not an option because smaller hoses significantly increase the air velocity at a given flow rate. This increase in the air velocity at a given flow rate leads to high noise and a high pressure drop; both of which are undesirable.
  • a respiratory interface device that includes a patient circuit that is less noticeable to the user while not generating high noise and a high pressure drop.
  • EP 1655052 discloses a wearable system for positive airway pressure therapy, comprising a mask and an air pump system.
  • US 2015/0320958 discloses a gas supply system for a patient interface for supplying a flow of pressurized gas to a subject.
  • US 2015/0059749 discloses a pump unit having a housing provided with an inlet and an outlet for a fluid.
  • One embodiment of the presently disclosed concept provides a respiratory interface device including a patient interface device, a patient circuit including a reduced, first conduit a pressure generating assembly including a first pressure generating device and a second pressure generating device.
  • the invention is defined by the appended claims. The embodiments disclosed herein are considered as examples unless defined as embodiments of the invention.
  • the first pressure generating device is structured to generate a first pressure and the second pressure generating device is structured to generate a second pressure.
  • the first pressure generating device is coupled to, and in fluid communication, with the first conduit.
  • the first conduit is coupled to, and in fluid communication, with the patient interface device.
  • the second pressure generating device is coupled to, and in fluid communication, with the second conduit.
  • the second conduit is coupled to, and in fluid communication, with the patient interface device.
  • the word "unitary” means a component is created as a single piece or unit. That is, a component that includes pieces that are created separately and then coupled together as a unit is not a “unitary” component or body.
  • the statement that two or more parts or components "engage” one another shall mean that the parts exert a force against one another either directly or through one or more intermediate parts or components.
  • the term “number” shall mean one or an integer greater than one ( i.e., a plurality).
  • a “reduced” hose, conduit, or similar construct is a construct that is coupled to, and in fluid communication with a patient interface device that is also in fluid communication with two separate pressure generating devices. That is, a "reduced" hose has a smaller diameter relative to a hose in fluid communication with a patient interface device and a single pressure generating device. It is understood that such a hose, in an exemplary embodiment, has a smaller diameter than would be required for a hose operating with a single pressure generating device.
  • FIGS. 1 and 1A show a respiratory interface device 10.
  • Respiratory interface device 10 includes a pressure generating assembly 20, a patient circuit 30, and a patient interface device 50.
  • Pressure generating assembly 20 includes a plurality of pressure generating devices; as shown, a number of first pressure generating devices 22 and a number of second pressure generating devices 24, it is, however, understood that pressure generating assembly 20 is not limited to two pressure generating devices.
  • a plurality of second pressure generating devices 24', 24" which are similar to each other are shown directly coupled to patient interface device 50.
  • first pressure generating device 22 is the primary pressure generating device and second pressure generating device 24 is a secondary pressure generating device. That is, as used herein, the "primary" pressure generating device(s) is structured to generate a greater volume of fluid flow relative to a number of "secondary" pressure generating device(s).
  • primary pressure generating device 22 is coupled to patient interface device 50 by a "reduced" conduit 32 while second pressure generating device 24 is directly coupled to patient interface device 50..
  • primary pressure generating device 22 is directly coupled to patient interface device 50 while secondary pressure generating device 24 is coupled to patient interface device 50 by reduced conduit 32.
  • pressure generating assembly 20 includes any device capable of generating a flow of breathing gas or providing gas at an elevated pressure.
  • pressure generating systems include a ventilator, CPAP device, or variable pressure device, e.g., an auto-titrating device, proportional assist ventilation (PAV.RTM.) device, proportional positive airway pressure (PPAP) device, C-Flex.TM. device, Bi-Flex.RTM. device, or a BiPAP.RTM. device manufactured and distributed by Philips Respironics of Murrysville, PA, in which the pressure provided to the patient varies with the patient's respiratory cycle so that a higher pressure is delivered during inspiration than during expiration, or other pressure support device.
  • PAV.RTM. proportional assist ventilation
  • PPAP proportional positive airway pressure
  • C-Flex.TM. device C-Flex.TM. device
  • Bi-Flex.RTM. device Bi-Flex.RTM. device
  • BiPAP.RTM. device BiPAP
  • primary pressure generating device 22 is such a device.
  • first pressure generating device 22 is structured to generate a pressure of between about 4 cmH2O and 50 cmH2O
  • second pressure generating device 24 is structured to generate a pressure of between about 4 cmH2O and 30 cmH2O.
  • the combined flow rate/pressure of first pressure generating device 22 and second pressure generating device 24 generally corresponds to the flow rate/pressure of a prior art pressure generating device.
  • Second pressure generating device 24 in an exemplary embodiment, is smaller, i.e., second pressure generating device 24 has any of a smaller size, footprint, volume and/or operating characteristics, than first pressure generating device 22 and is coupled, directly coupled, or fixed to patient interface device 50 or to first conduit 32, as discussed below.
  • Second pressure generating device 24 is selected from the group including, or consisting of, a piezoelectric micro blower 24A ( FIG. 1 ), a diaphragm blower 24B ( FIG. 2 ), and a centrifugal blower 24C ( FIG. 3 ).
  • second pressure generating device 24 includes a housing assembly 100, a micro-blower 102 (shown schematically), and a pressure sensor 104.
  • Second pressure generating device housing assembly 100 defines a substantially enclosed space (not shown).
  • Second pressure generating device micro-blower 102 is structured to be, and is, disposed in second pressure generating device housing assembly enclosed space.
  • second pressure generating device housing assembly 100 defines an inlet 110 and an outlet 112.
  • Second pressure generating device micro-blower 102 is structured to be, and is, in fluid communication with second pressure generating device housing assembly inlet 110 and second pressure generating device housing assembly outlet 112.
  • second pressure generating device micro-blower 102 is structured to, and does, create a fluid flow from second pressure generating device housing assembly inlet 110 to second pressure generating device housing assembly outlet 112.
  • second pressure generating device housing assembly inlet 110 is second conduit 34, discussed below, and is, in an exemplary embodiment, a first tubular extension 114 on second pressure generating device housing assembly 100.
  • second conduit 34 does not have to exist as a visible construct, such as tubular extension 114, but rather second conduit 34 is, in an exemplary embodiment, defined as a passage in housing assembly 100.
  • second pressure generating device housing assembly 100 is structured to be coupled, directly coupled, or fixed to patient interface device 50 or to first conduit 32 (shown in FIGS. 7 and 7A ).
  • Second pressure generating device housing assembly inlet 110 is disposed outside of patient interface device interior surface 60 or first conduit 32. Thus, second pressure generating device housing assembly inlet 110 is exposed to the atmosphere.
  • second pressure generating device housing assembly outlet 112 is a second tubular extension 116 on second pressure generating device housing assembly 100.
  • Second pressure generating device housing assembly outlet 112 is structured to, and does, extend through patient interface device 50 or first conduit 32 so as to provide fluid communication between the area near patient interface device interior surface 60, i.e., within the space defined by the user's face and patient interface device 50, or, interior of first conduit 32.
  • second pressure generating device housing assembly 100 defines a pressure sensor mounting 120.
  • pressure sensor mounting 120 is a hollow tube 118 structured to, and does, extend through patient interface device 50 or first conduit 32 so as to provide fluid communication between the area near patient interface device interior surface 60 or interior of first conduit 32.
  • pressure sensor 104 is disposed within second pressure generating device housing assembly 100 and is exposed to the fluid pressure adjacent the user's face via pressure sensor mounting 120.
  • pressure sensor mounting 120 is a substantially solid member 119 structured to, and does, extend through patient interface device 50 or first conduit 32. In this embodiment, pressure sensor 104 is disposed on pressure sensor mounting 120.
  • pressure sensor 104 is disposed within patient interface device 50 or first conduit 32. As is known, pressure sensor 104 is structured to measure pressure and to produce a signal including data representing the measured pressure.
  • pressure generating assembly 20 includes control unit 26 as well as a number of conductors 28.
  • Pressure generating assembly conductors 28 are structured to transmit a current that is used to power second pressure generating device 24 and/or pressure sensor 104, or, to transmit a current that is used to transmit a data signal. Further, in this embodiment, pressure generating assembly conductors 28 extend through patient circuit conduit(s) 32, 34, discussed below. That is, pressure generating assembly conductors 28 are coupled, directly coupled, or fixed to patient circuit conduit(s) 32, 34.
  • Patient circuit 30 is structured to provide fluid communication between each pressure generating device 22, 24, of pressure generating assembly 20 and patient interface device 50.
  • Patient circuit 30 includes a number of conduits 32, 34 (shown and discussed below), hoses, tubes, pipes, or other constructs that define passages (none shown). At least one of patient circuit conduit 32, 34, (or hoses, tubes, pipes, or other constructs that define passages) is a "reduced" conduit 32, 34 as defined above.
  • patient circuit 30 includes first conduit 32 and second conduit 34.
  • First patient circuit conduit 32 includes a generally flexible, hollow body 36 with a first end 38 and a second end 39. At least one of first conduit 32 and second conduit 34 has a diameter between about 4 mm and 22 mm, or between about 4 mm and 14 mm, or less than 15 mm.
  • Conduits with a diameter that is smaller than the prior art along with a system that provide a total pressure comparable to the prior art solve the problems stated above. It is understood that conduits 32, 34 having a circular cross-section are exemplary and that conduits of any shape are included. That is, as used herein, the recitation of a conduit with a "diameter" also includes any conduit having a cross-sectional area similar to a conduit of the stated diameter.
  • first conduit 32 has a first length and second conduit 34 has a second length.
  • the second length is physically shorter than the first length.
  • the "physical" length of a conduit means the length when the conduit is extended to a maximum. That is, it is understood that a conduit may be made from a flexible material that can be bent, coiled, or otherwise manipulated so as to have a length that is shorter than the maximum length.
  • the "physical" length of a conduit means the length when the conduit is extended to a maximum.
  • second conduit 34 has a second length of between about 0.0 inches to 24.0 inches.
  • first pressure generating device 22 is directly coupled to patient interface device 50 and first conduit 32 has a first length of about 0.0 inches while second conduit 34 is a reduced conduit as defined above. It is noted that a conduit having a length that is smaller than a prior art hose solves the problems stated above.
  • Patient interface device 50 is shown as a nasal interface device 52. It is understood, however, that patient interface device 50 can include, without limitation, an oral/nasal mask, nasal pillows, or any other device that provides a suitable gas flow communicating function. Thus, as used herein, the term “patient interface device” shall refer to any of such devices.
  • Patient interface device 50 is coupled to, and in fluid communication with, pressure generating assembly 20 via patient circuit 30. That is, patient interface device 50 is coupled to, and in fluid communication, with first conduit 32 and patient interface device 50 is coupled to, and in fluid communication, with second conduit 34. Further, as discussed above, second conduit 34 is, in one embodiment, incorporated into second pressure generating device 24 which is coupled, directly coupled, or fixed to patient interface device 50 or first conduit 32.
  • Patient interface device 50 includes an interior surface 60. As shown, in a nasal interface device 52, patient interface device interior surface 60 is within a number of hollow tubes 62 that are structured to, and do, extend from first conduit 32 to an area adjacent a user's nose. In an oral/nasal mask 54 ( Figure 7 ) patient interface device interior surface 60 is the surface of patient interface device 50 on an inner surface of a concave mask. In an exemplary embodiment, patient interface device 50 includes a pressure sensor 70.
  • patient circuit conduit 32 extends from first pressure generating device 22 to second pressure generating device 24. That is, first pressure generating device 22 is in direct fluid communication with second pressure generating device 24.
  • direct fluid communication between two pressure generating devices means that a fluid moves from an upstream pressure generating device to a downstream pressure generating device without passing through another construct, such as, but not limited to, a patient interface device.
  • primary, first pressure generating device 22 is not directly coupled to patient interface device 50, but rather is coupled thereto by a reduced conduit 32.
  • second pressure generating device 24 is directly coupled to patient interface device 50.
  • first pressure generating device 22 is disposed at a remote location, such as, but not limited to a nightstand, and is coupled to, and in fluid communication with, second pressure generating device 24 via reduced conduit 32.
  • Second pressure generating device 24 is directly coupled to, and is in fluid communication with, patient interface device 50. It is understood that fluid provided by first pressure generating device 22 passes through, and is combined with, the fluid generated by second pressure generating device 24.
  • primary, first pressure generating device 22 is directly coupled to patient interface device 50 and secondary, second pressure generating device 24 is disposed at a remote location and coupled to first pressure generating device 22 via reduced conduit 32.
  • a method of using a respiratory interface device 10, not part of the invention, as described above, includes: providing 1000 a respiratory interface device 10, positioning 1002 patient interface device 50 in a use position, operating 1004 first pressure generating device, and operating 1006 second pressure generating device.
  • a "use position" is a position wherein the respiratory interface device 10 is structured to deliver a gas to a user.
  • patient interface device 50 when in the "use position" patient interface device 50, or a portion thereof, is generally sealed against the user's skin.
  • Providing 1000 respiratory interface device 10 includes patient interface device 50, patient circuit including first conduit 32 and second conduit 34, and pressure generating assembly 20 including first pressure generating device 22 and second pressure generating device 24, first pressure generating device structured to generate a first pressure, second pressure generating device structured to generate a second pressure, first pressure generating device coupled to, and in fluid communication, with first conduit, first conduit coupled to, and in fluid communication, with the patient interface device, second pressure generating device coupled to, and in fluid communication, with second conduit, second conduit coupled to, and in fluid communication, with patient interface device.
  • respiratory interface device 10 includes a control assembly (not shown).
  • Control assembly is structured to receive a signal from pressure sensor 104. Further, control assembly is structured to alter the operation of first and second pressure generating devices 22, 24.
  • operating 1004 first pressure generating device 22 and operating 1006 second pressure generating device 24 include detecting 1010 a characteristic of the generated pressure and altering 1012 the pressure generated by at least one of first pressure generating device 22 and operating 1006 second pressure generating device 24.
  • a "characteristic of the generated pressure” includes, but is not limited to, the total pressure generated by first pressure generating device 22 and operating 1006 second pressure generating device 24.
  • first pressure generating device 22 operates continuously while second pressure generating device 24 operates 1020 upon detection of a selected characteristic of the generated pressure.
  • any reference signs placed between parentheses shall not be construed as limiting the claim.
  • the word “comprising” or “including” does not exclude the presence of elements or steps other than those listed in a claim.
  • several of these means may be embodied by one and the same item of hardware.
  • the word “a” or “an” preceding an element does not exclude the presence of a plurality of such elements.
  • any device claim enumerating several means several of these means may be embodied by one and the same item of hardware
  • the mere fact that certain elements are recited in mutually different dependent claims does not indicate that these elements cannot be used in combination.

Claims (11)

  1. Dispositif d'interface respiratoire (10) comprenant :
    un dispositif d'interface patient (50) ;
    un circuit patient (30) ;
    un ensemble de génération de pression (20) comprenant un nombre de dispositifs de génération de première pression (22) et un nombre de dispositifs de génération de seconde pression (24) ;
    le nombre de dispositifs de génération de première pression structuré pour générer une première pression ;
    le nombre de dispositifs de génération de seconde pression structuré pour générer une seconde pression ;
    le nombre de dispositifs de génération de première pression couplé, et en communication fluide avec le circuit patient ;
    le circuit patient couplé et en communication fluide avec le dispositif d'interface patient ; et
    le nombre de dispositifs de génération de seconde pression couplé et en communication fluide avec le dispositif d'interface patient ;
    caractérisé en ce que le nombre de dispositifs de génération de première pression est structuré pour générer un plus grand volume de flux de fluide par rapport au nombre de dispositifs de génération de seconde pression ; et dans lequel le nombre de dispositifs de génération de seconde pression a une taille, une empreinte et/ou un volume plus faible que le nombre de dispositifs de génération de première pression.
  2. Dispositif d'interface respiratoire (10) selon la revendication 1, dans lequel le nombre de dispositifs de génération de seconde pression (24) est directement couplé et en communication fluide avec le dispositif d'interface patient (50).
  3. Dispositif d'interface respiratoire (10) selon la revendication 2, dans lequel le nombre de dispositifs de génération de première pression (22) est couplé au dispositif d'interface patient (50) par un conduit réduit (32).
  4. Dispositif d'interface respiratoire (10) selon la revendication 2, dans lequel le conduit réduit (32) a un diamètre entre environ 4 mm et 14 mm.
  5. Dispositif d'interface respiratoire (10) selon la revendication 4, dans lequel le conduit réduit (32) a un diamètre de moins de 15 mm.
  6. Dispositif d'interface respiratoire (10) selon la revendication 2, dans lequel le conduit réduit (32) a une première longueur ; et dans lequel un second conduit (34) a une seconde longueur ; et dans lequel la seconde longueur est physiquement plus courte que la première longueur.
  7. Dispositif d'interface respiratoire (10) selon la revendication 2, dans lequel le nombre de dispositifs de génération de seconde pression (24) est couplé directement au dispositif d'interface patient (50) ou couplé à un conduit réduit (32).
  8. Dispositif d'interface respiratoire (10) selon la revendication 7, dans lequel :
    l'ensemble de génération de pression (20) comprend un nombre de conducteurs (28) ; et dans lequel les conducteurs sont directement couplés au conduit réduit.
  9. Dispositif d'interface respiratoire (10) selon la revendication 2, dans lequel le nombre de dispositifs de génération de seconde pression (24) est choisi parmi le groupe comprenant un micro-souffleur piézoélectrique, un souffleur à membrane, et un souffleur centrifuge.
  10. Dispositif d'interface respiratoire (10) selon la revendication 2, dans lequel :
    un conduit réduit (32) a une première longueur ;
    un second conduit (34) a une seconde longueur ; et
    dans lequel ladite première longueur est physiquement plus courte que la seconde longueur.
  11. Dispositif d'interface respiratoire (10) selon la revendication 2, dans lequel le nombre de dispositifs de génération de première pression (22) est placé sur l'un des dispositifs d'interface patient (50) ou sur un second conduit (34).
EP17822191.7A 2016-12-13 2017-12-08 Masque avec apport d'air primaire et secondaire Active EP3554648B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662433286P 2016-12-13 2016-12-13
PCT/EP2017/081940 WO2018108715A1 (fr) 2016-12-13 2017-12-08 Masque avec apport d'air primaire et secondaire

Publications (2)

Publication Number Publication Date
EP3554648A1 EP3554648A1 (fr) 2019-10-23
EP3554648B1 true EP3554648B1 (fr) 2021-06-16

Family

ID=60857034

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17822191.7A Active EP3554648B1 (fr) 2016-12-13 2017-12-08 Masque avec apport d'air primaire et secondaire

Country Status (5)

Country Link
US (1) US11339770B2 (fr)
EP (1) EP3554648B1 (fr)
JP (1) JP7256121B2 (fr)
CN (1) CN110072596A (fr)
WO (1) WO2018108715A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD924388S1 (en) * 2018-07-10 2021-07-06 ResMed Pty Ltd Patient interface
USD942614S1 (en) * 2018-07-10 2022-02-01 ResMed Pty Ltd Combined cushion and frame module for patient interface
USD942615S1 (en) 2018-09-12 2022-02-01 ResMed Pty Ltd Patient interface

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN973596A0 (en) 1996-05-08 1996-05-30 Resmed Limited Control of delivery pressure in cpap treatment or assisted respiration
US6257235B1 (en) 1999-05-28 2001-07-10 Kimberly-Clark Worldwide, Inc. Face mask with fan attachment
US6349724B1 (en) * 2000-07-05 2002-02-26 Compumedics Sleep Pty. Ltd. Dual-pressure blower for positive air pressure device
US7204252B2 (en) * 2001-12-21 2007-04-17 Eidon, Llc Surface energy assisted fluid transport system
CN1826151A (zh) * 2003-07-18 2006-08-30 阿科巴有限责任公司 分别控制患者两鼻孔气道压力的方法和系统
US7114497B2 (en) 2003-07-18 2006-10-03 Acoba, Llc Method and system of individually controlling airway pressure of a patient's nares
US20060096596A1 (en) * 2004-11-05 2006-05-11 Occhialini James M Wearable system for positive airway pressure therapy
US20080210242A1 (en) 2006-06-12 2008-09-04 Marc Alan Burk Mask-nebulizer-metered-dose-inhaler assembly
TW201039882A (en) * 2009-05-05 2010-11-16 Top Vision Medical Equipment Consultant Co Ltd Breathing device connected to air purification device
CN201894770U (zh) * 2010-10-13 2011-07-13 陈实 高强度负压脉动呼吸疾病治疗仪
US8844533B2 (en) 2011-06-22 2014-09-30 Breathe Technologies, Inc. Ventilation mask with integrated piloted exhalation valve
JP5636555B2 (ja) * 2012-04-02 2014-12-10 株式会社メトラン ポンプユニット、呼吸補助装置
CN104470572B (zh) 2012-06-07 2017-09-22 皇家飞利浦有限公司 儿科全面罩
US9669172B2 (en) * 2012-07-05 2017-06-06 Resmed Limited Discreet respiratory therapy system
CN104870040B (zh) * 2012-12-18 2017-08-29 皇家飞利浦有限公司 用于患者界面的eap驱动气泵
US9517367B2 (en) 2013-02-01 2016-12-13 3M Innovative Properties Company Respiratory mask having a clean air inlet chamber
US20140261425A1 (en) * 2013-03-13 2014-09-18 Robert A. Connor Wearable Positive Airway Pressure (PAP) with Primary and Bolus Airflow
US10344753B2 (en) * 2014-02-28 2019-07-09 Encite Llc Micro pump systems
US20160089261A1 (en) 2014-09-29 2016-03-31 Kenneth Quinn Respiratory Treatment Devices for Airway Obstruction Therapy and the Like

Also Published As

Publication number Publication date
JP2020512037A (ja) 2020-04-23
WO2018108715A1 (fr) 2018-06-21
US20200078545A1 (en) 2020-03-12
EP3554648A1 (fr) 2019-10-23
CN110072596A (zh) 2019-07-30
JP7256121B2 (ja) 2023-04-11
US11339770B2 (en) 2022-05-24

Similar Documents

Publication Publication Date Title
US10617838B2 (en) Modular patient interface device with chamber and nasal pillows assembly
US9717873B2 (en) Rotating electrical connector ADN respiratory gas delivery system employing same
EP2914322B1 (fr) Canule nasale silencieuse
EP3034122A1 (fr) Adaptateur en ligne pour un dispositif de thérapie respiratoire
CN113226422A (zh) 具有磁性联接特征的患者界面装置
CN101765443A (zh) 具有柔性袖口状部件的减压阀
EP3554648B1 (fr) Masque avec apport d'air primaire et secondaire
US10493227B2 (en) Headgear tubing assembly and integrated pressure sensing
US11090456B2 (en) Liquid removal in a patient interface assembly
WO2012059840A1 (fr) Système de gestion de conduit d'administration de gaz
US10369316B2 (en) Forhead gas supply assembly for a patient interface system
US11273279B2 (en) Magnetic anti-crush feature for conduit
US10869985B2 (en) Flow member
US20220347410A1 (en) Compact fluid moving assembly and device employing same
US20170361050A1 (en) Adjustable airflow diffuser
WO2020064578A1 (fr) Système de gestion de tuyau pour équipement cpap

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190715

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KONINKLIJKE PHILIPS N.V.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20210129

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017040502

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1401829

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210715

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210916

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1401829

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210616

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20210616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210917

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210916

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211018

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602017040502

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

26N No opposition filed

Effective date: 20220317

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20211231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211208

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211231

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211231

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20221222

Year of fee payment: 6

Ref country code: DE

Payment date: 20220628

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20171208

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231219

Year of fee payment: 7